February 23, 2016
Synthetic biology’s first malaria drug meets market resistance
news@nature.com - Fetched: February 23rd, 2016, 2:00pm UTC
Commercial use of genetically engineered yeast to make medicine has modest impact.
Nature 530 389 doi: 10.1038/530390a